Company Registration No. 06551157 (England and Wales)
WADE DENTAL LABORATORIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
WADE DENTAL LABORATORIES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
WADE DENTAL LABORATORIES LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
27,961
33,170
27,961
33,170
Current assets
Stocks
8,870
8,020
Debtors
5
114,692
107,811
Cash at bank and in hand
93,928
91,518
217,490
207,349
Creditors: amounts falling due within one year
6
(80,653)
(92,696)
Net current assets
136,837
114,653
Total assets less current liabilities
164,798
147,823
Provisions for liabilities
(6,991)
(8,293)
Net assets
157,807
139,530
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
157,707
139,430
Total equity
157,807
139,530

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

WADE DENTAL LABORATORIES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 22 July 2026 and are signed on its behalf by:
AV Nowak
Director
Company Registration No. 06551157
WADE DENTAL LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
1
Accounting policies
Company information

Wade Dental Laboratories Limited is a private company limited by shares incorporated in England and Wales. The registered office is 209 Rayleigh Road, Hutton, Brentwood, Essex, CM13 1LZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for goods and services net of trade discounts.

1.3
Intangible fixed assets - goodwill

Positive goodwill is capitalised, classified as an asset on the balance sheet and amortised on a straight line basis over its useful economic life. It is reviewed for impairment at the end of the first full financial year following the acquisition and in other periods if events or changes in circumstances indicate that the carrying value may not be recoverable.

Amortisation

Amortisation is provided on intangible fixed assets so as to write off the cost, less any estimated

residual value, over their expected useful economic life as follows:

Goodwill 1 0 years straight line

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings - Leasehold
9 years straight line
Plant and machinery
25% reducing balance
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

WADE DENTAL LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

WADE DENTAL LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

WADE DENTAL LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
7
10
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2025 and 31 March 2026
500,000
Amortisation and impairment
At 1 April 2025 and 31 March 2026
500,000
Carrying amount
At 31 March 2026
-
0
At 31 March 2025
-
0
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2025
3,816
239,536
243,352
Additions
-
0
3,385
3,385
At 31 March 2026
3,816
242,921
246,737
Depreciation and impairment
At 1 April 2025
3,816
206,366
210,182
Depreciation charged in the year
-
0
8,594
8,594
At 31 March 2026
3,816
214,960
218,776
Carrying amount
At 31 March 2026
-
0
27,961
27,961
At 31 March 2025
-
0
33,170
33,170
WADE DENTAL LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 7 -
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
111,737
104,711
Amounts owed by group undertakings
1,026
1,026
Other debtors
1,929
2,074
114,692
107,811
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
15,351
19,388
Taxation and social security
53,964
61,315
Other creditors
11,338
11,993
80,653
92,696
7
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2026
2025
£
£
Total commitments
7,250
21,000
2026-03-31 2025-04-01 false false false 23 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity ML G Wade AJ Wade AV Nowak AJ Wade 06551157 2025-04-01 2026-03-31 06551157 2026-03-31 06551157 2025-03-31 06551157 core:LandBuildings 2026-03-31 06551157 core:OtherPropertyPlantEquipment 2026-03-31 06551157 core:LandBuildings 2025-03-31 06551157 core:OtherPropertyPlantEquipment 2025-03-31 06551157 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 06551157 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06551157 core:CurrentFinancialInstruments 2026-03-31 06551157 core:CurrentFinancialInstruments 2025-03-31 06551157 core:ShareCapital 2026-03-31 06551157 core:ShareCapital 2025-03-31 06551157 core:RetainedEarningsAccumulatedLosses 2026-03-31 06551157 core:RetainedEarningsAccumulatedLosses 2025-03-31 06551157 bus:Director2 2025-04-01 2026-03-31 06551157 core:Goodwill 2025-04-01 2026-03-31 06551157 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-04-01 2026-03-31 06551157 core:PlantMachinery 2025-04-01 2026-03-31 06551157 2024-04-01 2025-03-31 06551157 core:NetGoodwill 2025-03-31 06551157 core:NetGoodwill 2026-03-31 06551157 core:NetGoodwill 2025-03-31 06551157 core:LandBuildings 2025-03-31 06551157 core:OtherPropertyPlantEquipment 2025-03-31 06551157 2025-03-31 06551157 core:LandBuildings 2025-04-01 2026-03-31 06551157 core:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 06551157 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 06551157 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 06551157 bus:FRS102 2025-04-01 2026-03-31 06551157 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 06551157 bus:Director1 2025-04-01 2026-03-31 06551157 bus:Director3 2025-04-01 2026-03-31 06551157 bus:CompanySecretary1 2025-04-01 2026-03-31 06551157 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP